Hepatitis C virus (HCV) infection is a major cause of liver disease characterized by inflammation, cell damage, and fibrotic reactions of hepatocytes. Apoptosis has been implicated in the pathogenesis, although it is unclear whether proteases of the caspase family as the central executioners of apoptosis are involved and how caspase activation contributes to liver injury. In the present study, we measured the activation of effector caspases in liver biopsy specimens of patients with chronic HCV infection. The activation of caspase-3, caspase-7, and cleavage of poly(ADP-ribose)polymerase (PARP), a specific caspase substrate, were measured by immunohistochemistry and Western blot analysis by using antibodies that selectively detect the active truncated, but not the inactive precursor forms of the caspases and PARP. We found that caspase activation was considerably elevated in liver lobules of HCV patients in comparison to normal controls. Interestingly, the immunoreactive cells did yet not reveal an overt apoptotic morphology. The extent of caspase activation correlated significantly with the disease grade, i.e., necroinflammatory activity. In contrast, no correlation was observed with other surrogate markers such as serum transaminases and viral load. In biopsy specimens with low activity ( Hepatitis C virus (HCV) infection is one of the major causes of liver disease with an increased risk of cirrhosis and hepatocellular carcinoma. The infection has a high propensity to chronicity, and the majority of HCV carriers have histologic evidence for liver inflammation, cell damage, and fibrotic reactions of hepatocytes. The mechanisms responsible for HCVmediated liver cell damage are poorly understood, and both immune-mediated reactions and direct cytopathic effects of HCV may be involved in its pathogenesis. It has been suggested that apoptosis plays an important role in HCV-associated liver injury, 1-4 although it is unclear which cellular and molecular mechanisms participate in the process.One of the best-defined apoptotic pathways is mediated by the death receptor CD95, a member of the tumor necrosis factor superfamily that is constitutively expressed on hepatocytes. 5 Experiments in mice have shown that agonistic CD95 antibodies cause massive liver cell lysis, resulting in increased serum levels of transaminases and death from fulminant hepatic failure. 6 In patients with chronic HCV infection, expression of CD95 is increased and associated with disease activity and the severity of liver inflammation. 7,8 When HCV-specific T cells migrate towards hepatocytes and recognize viral antigens through the T-cell receptor, they become activated and inducibly express the ligand CD95L that can transduce the apoptotic death signal to CD95-bearing hepatocytes. 2 In addition to CD95L and other cytokines, both structural and nonstructural HCV proteins have been shown to modulate the sensitivity of hepatocytes for cell death. [9][10][11][12][13] Cells undergoing apoptosis show a sequence of morphologic features including membrane...